Wujuan Zhong
Research Subjects
Wujuan Zhong has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Yun Li
Department of Biostatistics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA
8 shared publications - Jason Peter Fine
Department of Biostatistics The University of North Carolina at Chapel Hill Chapel Hill North Carolina USA
4 shared publications - Ming Hu
The Tony and Leona Campane Center for Excellence in Image-Guided Surgery and Advanced Imaging Research, Cleveland Clinic, Cleveland, OH 44195, USA
4 shared publications - Weifang Liu
Department of Biostatistics, University of North Carolina at Chapel Hill , 135 Dauer Drive, Chapel Hill, NC 27599, United States
4 shared publications - Xiaojing Zheng
Department of Pediatrics, University of North Carolina at Chapel Hill , Chapel Hill, North Carolina
4 shared publications - Cassandra Nichole Spracklen
Department of Biostatistics and Epidemiology, University of Massachusetts Amherst, Amherst, MA, USA
2 shared publications
Latest Publications
- Open Access
- 15 September 2026
- Published by Springer Nature in Research Square
Integrated Polygenic Risk Scores: Composite and Ensemble Learning Approaches for Precision Medicine
Pharmacogenomics (PGx) utilizes genetic information to predict drug response and optimize patient treatment. Polygenic risk scores (PRS) are a promising tool in the PGx field, aggregating the effects of multiple genetic variants to predict drug response and stratify patients. Existing PRS development strategies have significant limitations. A common approach using disease-related genome-wide association study (GWAS) summary statistics (PRS-Dis) usually fails in capturing predictive genetic effects, thereby limiting its capability in stratifying patients and explaining drug response heritability. An alternative, PRS based on PGx GWAS data from treated individuals (PRS-PGx-T), directly targets drug response but is often hindered by small sample sizes and its inability to distinguish between prognostic and predictive effects. To overcome these challenges, we first propose a naïve composite method, PRS-DisPGx-C, which integrates disease and PGx-T GWAS summary statistics on either PRS level (PRS-DisPGx-C-p) or variant level (PRS-DisPGx-C-v) to separately estimate the aggregated prognostic and predictive genetic effects. Our theoretical research work further indicates that the performance of an optimal PRS approach depends on the genetic correlation between disease and drug response, the correlation between base and target cohorts (e.g., between two prognostic effects), and the correlation between prognostic and predictive effects. This insight motivates us to extend our composite method into an adaptive ensemble approach, PRS-DisPGx-E(-p/v), which dynamically combines disease and PGx-T GWAS data with optimal weights to further enhance drug response prediction. In simulation studies under various scenarios, our proposed ensemble approach significantly outperforms the conventional PRS-Dis method based on R^2 and predictive p-value metrics. Application to the IMPROVE-IT PGx GWAS data demonstrates the practical utility of our methods for improved prediction of LDL cholesterol reduction and patient stratification.
- 15 September 2026
- Published by Springer Nature in Research Square
Open AccessIntegrated Polygenic Risk Scores: Composite and Ensemble Learning Approaches for Precision Medicine
Pharmacogenomics (PGx) utilizes genetic information to predict drug response and optimize patient treatment. Polygenic risk scores (PRS) are a promising tool in the PGx field, aggregating the effects of multiple genetic variants to predict drug response and stratify patients. Existing PRS development strategies have significant limitations. A common approach using disease-related genome-wide association study (GWAS) summary statistics (PRS-Dis) usually fails in capturing predictive genetic effects, thereby limiting its capability in stratifying patients and explaining drug response heritability. An alternative, PRS based on PGx GWAS data from treated individuals (PRS-PGx-T), directly targets drug response but is often hindered by small sample sizes and its inability to distinguish between prognostic and predictive effects. To overcome these challenges, we first propose a naïve composite method, PRS-DisPGx-C, which integrates disease and PGx-T GWAS summary statistics on either PRS level (PRS-DisPGx-C-p) or variant level (PRS-DisPGx-C-v) to separately estimate the aggregated prognostic and predictive genetic effects. Our theoretical research work further indicates that the performance of an optimal PRS approach depends on the genetic correlation between disease and drug response, the correlation between base and target cohorts (e.g., between two prognostic effects), and the correlation between prognostic and predictive effects. This insight motivates us to extend our composite method into an adaptive ensemble approach, PRS-DisPGx-E(-p/v), which dynamically combines disease and PGx-T GWAS data with optimal weights to further enhance drug response prediction. In simulation studies under various scenarios, our proposed ensemble approach significantly outperforms the conventional PRS-Dis method based on R^2 and predictive p-value metrics. Application to the IMPROVE-IT PGx GWAS data demonstrates the practical utility of our methods for improved prediction of LDL cholesterol reduction and patient stratification.
- Open Access
- 25 July 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (5)
SnapHiC-G: identifying long-range enhancer–promoter interactions from single-cell Hi-C data via a global background model
Harnessing the power of single-cell genomics technologies, single-cell Hi-C (scHi-C) and its derived technologies provide powerful tools to measure spatial proximity between regulatory elements and their target genes in individual cells. Using a global background model, we propose SnapHiC-G, a computational method, to identify long-range enhancer–promoter interactions from scHi-C data. We applied SnapHiC-G to scHi-C datasets generated from mouse embryonic stem cells and human brain cortical cells. SnapHiC-G achieved high sensitivity in identifying long-range enhancer–promoter interactions. Moreover, SnapHiC-G can identify putative target genes for noncoding genome-wide association study (GWAS) variants, and the genetic heritability of neuropsychiatric diseases is enriched for single-nucleotide polymorphisms (SNPs) within SnapHiC-G-identified interactions in a cell-type-specific manner. In sum, SnapHiC-G is a powerful tool for characterizing cell-type-specific enhancer–promoter interactions from complex tissues and can facilitate the discovery of chromatin interactions important for gene regulation in biologically relevant cell types.
- 25 July 2024
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 25 (5)
Open AccessSnapHiC-G: identifying long-range enhancer–promoter interactions from single-cell Hi-C data via a global background model
Harnessing the power of single-cell genomics technologies, single-cell Hi-C (scHi-C) and its derived technologies provide powerful tools to measure spatial proximity between regulatory elements and their target genes in individual cells. Using a global background model, we propose SnapHiC-G, a computational method, to identify long-range enhancer–promoter interactions from scHi-C data. We applied SnapHiC-G to scHi-C datasets generated from mouse embryonic stem cells and human brain cortical cells. SnapHiC-G achieved high sensitivity in identifying long-range enhancer–promoter interactions. Moreover, SnapHiC-G can identify putative target genes for noncoding genome-wide association study (GWAS) variants, and the genetic heritability of neuropsychiatric diseases is enriched for single-nucleotide polymorphisms (SNPs) within SnapHiC-G-identified interactions in a cell-type-specific manner. In sum, SnapHiC-G is a powerful tool for characterizing cell-type-specific enhancer–promoter interactions from complex tissues and can facilitate the discovery of chromatin interactions important for gene regulation in biologically relevant cell types.
- Open Access
SnapHiC-G: identifying long-range enhancer-promoter interactions from single-cell Hi-C data via a global background model
Harnessing the power of single-cell genomics technologies, single-cell Hi-C (scHi-C) and its derived technologies provide powerful tools to measure spatial proximity between regulatory elements and their target genes in individual cells. Using a global background model, we propose SnapHiC-G, a computational method to identify long-range enhancer-promoter interactions from scHi-C data. We applied SnapHiC-G to scHi-C datasets generated from mouse embryonic stem cells and human brain cortical cells and demonstrated that SnapHiC-G achieved high sensitivity in identifying long-range enhancer-promoter interactions. Moreover, SnapHiC-G can identify putative target genes for non-coding GWAS variants, and the genetic heritability of neuropsychiatric diseases is enriched for single nucleotide polymorphisms (SNPs) within SnapHiC-G-identified interactions in a cell-type-specific manner. In sum, SnapHiC-G is a powerful tool for characterizing cell-type-specific enhancer-promoter interactions from complex tissues and can facilitate the discovery of chromatin interactions important for gene regulation in biologically relevant cell types.
Open AccessSnapHiC-G: identifying long-range enhancer-promoter interactions from single-cell Hi-C data via a global background model
Harnessing the power of single-cell genomics technologies, single-cell Hi-C (scHi-C) and its derived technologies provide powerful tools to measure spatial proximity between regulatory elements and their target genes in individual cells. Using a global background model, we propose SnapHiC-G, a computational method to identify long-range enhancer-promoter interactions from scHi-C data. We applied SnapHiC-G to scHi-C datasets generated from mouse embryonic stem cells and human brain cortical cells and demonstrated that SnapHiC-G achieved high sensitivity in identifying long-range enhancer-promoter interactions. Moreover, SnapHiC-G can identify putative target genes for non-coding GWAS variants, and the genetic heritability of neuropsychiatric diseases is enriched for single nucleotide polymorphisms (SNPs) within SnapHiC-G-identified interactions in a cell-type-specific manner. In sum, SnapHiC-G is a powerful tool for characterizing cell-type-specific enhancer-promoter interactions from complex tissues and can facilitate the discovery of chromatin interactions important for gene regulation in biologically relevant cell types.
- Open Access
- 21 December 2022
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 24 (1)
A fast and powerful linear mixed model approach for genotype-environment interaction tests in large-scale GWAS
Genotype-by-environment interaction (GEI or GxE) plays an important role in understanding complex human traits. However, it is usually challenging to detect GEI signals efficiently and accurately while adjusting for population stratification and sample relatedness in large-scale genome-wide association studies (GWAS). Here we propose a fast and powerful linear mixed model-based approach, fastGWA-GE, to test for GEI effect and G + GxE joint effect. Our extensive simulations show that fastGWA-GE outperforms other existing GEI test methods by controlling genomic inflation better, providing larger power and running hundreds to thousands of times faster. We performed a fastGWA-GE analysis of ~7.27 million variants on 452 249 individuals of European ancestry for 13 quantitative traits and five environment variables in the UK Biobank GWAS data and identified 96 significant signals (72 variants across 57 loci) with GEI test P-values < 1 × 10−9, including 27 novel GEI associations, which highlights the effectiveness of fastGWA-GE in GEI signal discovery in large-scale GWAS.
- 21 December 2022
- Published by Oxford University Press (OUP) in Briefings in Bioinformatics
- Vol. 24 (1)
Open AccessA fast and powerful linear mixed model approach for genotype-environment interaction tests in large-scale GWAS
Genotype-by-environment interaction (GEI or GxE) plays an important role in understanding complex human traits. However, it is usually challenging to detect GEI signals efficiently and accurately while adjusting for population stratification and sample relatedness in large-scale genome-wide association studies (GWAS). Here we propose a fast and powerful linear mixed model-based approach, fastGWA-GE, to test for GEI effect and G + GxE joint effect. Our extensive simulations show that fastGWA-GE outperforms other existing GEI test methods by controlling genomic inflation better, providing larger power and running hundreds to thousands of times faster. We performed a fastGWA-GE analysis of ~7.27 million variants on 452 249 individuals of European ancestry for 13 quantitative traits and five environment variables in the UK Biobank GWAS data and identified 96 significant signals (72 variants across 57 loci) with GEI test P-values < 1 × 10−9, including 27 novel GEI associations, which highlights the effectiveness of fastGWA-GE in GEI signal discovery in large-scale GWAS.
- Open Access
- 19 August 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 957292
Understanding the function of regulatory DNA interactions in the interpretation of non-coding GWAS variants
Genome-wide association studies (GWAS) have identified a vast number of variants associated with various complex human diseases and traits. However, most of these GWAS variants reside in non-coding regions producing no proteins, making the interpretation of these variants a daunting challenge. Prior evidence indicates that a subset of non-coding variants detected within or near cis-regulatory elements (e.g., promoters, enhancers, silencers, and insulators) might play a key role in disease etiology by regulating gene expression. Advanced sequencing- and imaging-based technologies, together with powerful computational methods, enabling comprehensive characterization of regulatory DNA interactions, have substantially improved our understanding of the three-dimensional (3D) genome architecture. Recent literature witnesses plenty of examples where using chromosome conformation capture (3C)-based technologies successfully links non-coding variants to their target genes and prioritizes relevant tissues or cell types. These examples illustrate the critical capability of 3D genome organization in annotating non-coding GWAS variants. This review discusses how 3D genome organization information contributes to elucidating the potential roles of non-coding GWAS variants in disease etiology.
- 19 August 2022
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 10, 957292
Open AccessUnderstanding the function of regulatory DNA interactions in the interpretation of non-coding GWAS variants
Genome-wide association studies (GWAS) have identified a vast number of variants associated with various complex human diseases and traits. However, most of these GWAS variants reside in non-coding regions producing no proteins, making the interpretation of these variants a daunting challenge. Prior evidence indicates that a subset of non-coding variants detected within or near cis-regulatory elements (e.g., promoters, enhancers, silencers, and insulators) might play a key role in disease etiology by regulating gene expression. Advanced sequencing- and imaging-based technologies, together with powerful computational methods, enabling comprehensive characterization of regulatory DNA interactions, have substantially improved our understanding of the three-dimensional (3D) genome architecture. Recent literature witnesses plenty of examples where using chromosome conformation capture (3C)-based technologies successfully links non-coding variants to their target genes and prioritizes relevant tissues or cell types. These examples illustrate the critical capability of 3D genome organization in annotating non-coding GWAS variants. This review discusses how 3D genome organization information contributes to elucidating the potential roles of non-coding GWAS variants in disease etiology.
- Open Access
Understanding Regulatory Mechanisms of Brain Function and Disease through 3D Genome Organization
The human genome has a complex and dynamic three-dimensional (3D) organization, which plays a critical role for gene regulation and genome function. The importance of 3D genome organization in brain development and function has been well characterized in a region- and cell-type-specific fashion. Recent technological advances in chromosome conformation capture (3C)-based techniques, imaging approaches, and ligation-free methods, along with computational methods to analyze the data generated, have revealed 3D genome features at different scales in the brain that contribute to our understanding of genetic mechanisms underlying neuropsychiatric diseases and other brain-related traits. In this review, we discuss how these advances aid in the genetic dissection of brain-related traits.
Open AccessUnderstanding Regulatory Mechanisms of Brain Function and Disease through 3D Genome Organization
The human genome has a complex and dynamic three-dimensional (3D) organization, which plays a critical role for gene regulation and genome function. The importance of 3D genome organization in brain development and function has been well characterized in a region- and cell-type-specific fashion. Recent technological advances in chromosome conformation capture (3C)-based techniques, imaging approaches, and ligation-free methods, along with computational methods to analyze the data generated, have revealed 3D genome features at different scales in the brain that contribute to our understanding of genetic mechanisms underlying neuropsychiatric diseases and other brain-related traits. In this review, we discuss how these advances aid in the genetic dissection of brain-related traits.
- 13 January 2021
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 78 (1) , 364-375
Generalized multi‐SNP mediation intersection–union test
To elucidate the molecular mechanisms underlying genetic variants identified from genome‐wide association studies (GWAS) for a variety of phenotypic traits encompassing binary, continuous, count, and survival outcomes, we propose a novel and flexible method to test for mediation that can simultaneously accommodate multiple genetic variants and different types of outcome variables. Specifically, we employ the intersection–union test approach combined with the likelihood ratio test to detect mediation effect of multiple genetic variants via some mediator (e.g., the expression of a neighboring gene) on outcome. We fit high‐dimensional generalized linear mixed models under the mediation framework, separately under the null and alternative hypothesis. We leverage Laplace approximation to compute the marginal likelihood of outcome and use coordinate descent algorithm to estimate corresponding parameters. Our extensive simulations demonstrate the validity of our proposed methods and substantial, up to 97%, power gains over alternative methods. Applications to real data for the study of Chlamydia trachomatis infection further showcase advantages of our methods. We believe our proposed methods will be of value and general interest in this post‐GWAS era to disentangle the potential causal mechanism from DNA to phenotype for new drug discovery and personalized medicine.
- 13 January 2021
- Published by Oxford University Press (OUP) in Biometrics
- Vol. 78 (1) , 364-375
Generalized multi‐SNP mediation intersection–union test
To elucidate the molecular mechanisms underlying genetic variants identified from genome‐wide association studies (GWAS) for a variety of phenotypic traits encompassing binary, continuous, count, and survival outcomes, we propose a novel and flexible method to test for mediation that can simultaneously accommodate multiple genetic variants and different types of outcome variables. Specifically, we employ the intersection–union test approach combined with the likelihood ratio test to detect mediation effect of multiple genetic variants via some mediator (e.g., the expression of a neighboring gene) on outcome. We fit high‐dimensional generalized linear mixed models under the mediation framework, separately under the null and alternative hypothesis. We leverage Laplace approximation to compute the marginal likelihood of outcome and use coordinate descent algorithm to estimate corresponding parameters. Our extensive simulations demonstrate the validity of our proposed methods and substantial, up to 97%, power gains over alternative methods. Applications to real data for the study of Chlamydia trachomatis infection further showcase advantages of our methods. We believe our proposed methods will be of value and general interest in this post‐GWAS era to disentangle the potential causal mechanism from DNA to phenotype for new drug discovery and personalized medicine.
- Open Access
Generalized Multi-SNP Mediation Intersection-Union Test
S ummary: To elucidate the molecular mechanisms underlying genetic variants identified from genome-wide association studies (GWAS) for a variety of phenotypic traits encompassing binary, continuous, count, and survival outcomes, we propose a novel and flexible method to test for mediation that can simultaneously accommodate multiple genetic variants and different types of outcome variables. Specifically, we employ the intersection-union test approach combined with likelihood ratio test to detect mediation effect of multiple genetic variants via some mediator (for example, the expression of a neighboring gene) on outcome. We fit high-dimensional generalized linear mixed models under the mediation framework, separately under the null and alternative hypothesis. We leverage Laplace approximation to compute the marginal likelihood of outcome and use coordinate descent algorithm to estimate corresponding parameters. Our extensive simulations demonstrate the validity of our proposed method and substantial, up to 97%, power gains over alternative methods. Applications to real data for the study of Chlamydia trachomatis infection further showcase advantages of our method. We believe our proposed method will be of value and general interest in this post-GWAS era to disentangle the potential causal mechanism from DNA to phenotype for new drug discovery and personalized medicine.
Open AccessGeneralized Multi-SNP Mediation Intersection-Union Test
S ummary: To elucidate the molecular mechanisms underlying genetic variants identified from genome-wide association studies (GWAS) for a variety of phenotypic traits encompassing binary, continuous, count, and survival outcomes, we propose a novel and flexible method to test for mediation that can simultaneously accommodate multiple genetic variants and different types of outcome variables. Specifically, we employ the intersection-union test approach combined with likelihood ratio test to detect mediation effect of multiple genetic variants via some mediator (for example, the expression of a neighboring gene) on outcome. We fit high-dimensional generalized linear mixed models under the mediation framework, separately under the null and alternative hypothesis. We leverage Laplace approximation to compute the marginal likelihood of outcome and use coordinate descent algorithm to estimate corresponding parameters. Our extensive simulations demonstrate the validity of our proposed method and substantial, up to 97%, power gains over alternative methods. Applications to real data for the study of Chlamydia trachomatis infection further showcase advantages of our method. We believe our proposed method will be of value and general interest in this post-GWAS era to disentangle the potential causal mechanism from DNA to phenotype for new drug discovery and personalized medicine.
- Open Access
- 25 April 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (22) , 4724-4729
Multi-SNP mediation intersection-union test
Tens of thousands of reproducibly identified GWAS (Genome-Wide Association Studies) variants, with the vast majority falling in non-coding regions resulting in no eventual protein products, call urgently for mechanistic interpretations. Although numerous methods exist, there are few, if any methods, for simultaneously testing the mediation effects of multiple correlated SNPs via some mediator (e.g. the expression of a gene in the neighborhood) on phenotypic outcome. We propose multi-SNP mediation intersection-union test (SMUT) to fill in this methodological gap. Our extensive simulations demonstrate the validity of SMUT as well as substantial, up to 92%, power gains over alternative methods. In addition, SMUT confirmed known mediators in a real dataset of Finns for plasma adiponectin level, which were missed by many alternative methods. We believe SMUT will become a useful tool to generate mechanistic hypotheses underlying GWAS variants, facilitating functional follow-up. The R package SMUT is publicly available from CRAN at https://CRAN.R-project.org/package=SMUT. Supplementary data are available at Bioinformatics online.
- 25 April 2019
- Published by Oxford University Press (OUP) in Bioinformatics
- Vol. 35 (22) , 4724-4729
Open AccessMulti-SNP mediation intersection-union test
Tens of thousands of reproducibly identified GWAS (Genome-Wide Association Studies) variants, with the vast majority falling in non-coding regions resulting in no eventual protein products, call urgently for mechanistic interpretations. Although numerous methods exist, there are few, if any methods, for simultaneously testing the mediation effects of multiple correlated SNPs via some mediator (e.g. the expression of a gene in the neighborhood) on phenotypic outcome. We propose multi-SNP mediation intersection-union test (SMUT) to fill in this methodological gap. Our extensive simulations demonstrate the validity of SMUT as well as substantial, up to 92%, power gains over alternative methods. In addition, SMUT confirmed known mediators in a real dataset of Finns for plasma adiponectin level, which were missed by many alternative methods. We believe SMUT will become a useful tool to generate mechanistic hypotheses underlying GWAS variants, facilitating functional follow-up. The R package SMUT is publicly available from CRAN at https://CRAN.R-project.org/package=SMUT. Supplementary data are available at Bioinformatics online.
- Open Access
Multi-SNP Mediation Intersection-Union Test
Tens of thousands of reproducibly identified GWAS (Genome-Wide Association Studies) variants, with the vast majority falling in non-coding regions resulting in no eventual protein products, call urgently for mechanistic interpretations. Although numerous methods exist, there are few, if any methods, for simultaneously testing the mediation effects of multiple correlated SNPs via some mediator (for example, the expression of a gene in the neighborhood) on phenotypic outcome. We propose SMUT, multi- S NP M ediation intersection- U nion T est to fill in this methodological gap. Our extensive simulations demonstrate the validity of SMUT as well as substantial, up to 92%, power gains over alternative methods. In addition, SMUT confirmed known mediators in a real dataset of Finns for plasma adiponectin level, which were missed by many alternative methods. We believe SMUT will become a useful tool to generate mechanistic hypotheses underlying GWAS variants, facilitating functional follow-up. The R package SMUT is publicly available from CRAN at https://CRAN.R-project.org/package=SMUT .
Open AccessMulti-SNP Mediation Intersection-Union Test
Tens of thousands of reproducibly identified GWAS (Genome-Wide Association Studies) variants, with the vast majority falling in non-coding regions resulting in no eventual protein products, call urgently for mechanistic interpretations. Although numerous methods exist, there are few, if any methods, for simultaneously testing the mediation effects of multiple correlated SNPs via some mediator (for example, the expression of a gene in the neighborhood) on phenotypic outcome. We propose SMUT, multi- S NP M ediation intersection- U nion T est to fill in this methodological gap. Our extensive simulations demonstrate the validity of SMUT as well as substantial, up to 92%, power gains over alternative methods. In addition, SMUT confirmed known mediators in a real dataset of Finns for plasma adiponectin level, which were missed by many alternative methods. We believe SMUT will become a useful tool to generate mechanistic hypotheses underlying GWAS variants, facilitating functional follow-up. The R package SMUT is publicly available from CRAN at https://CRAN.R-project.org/package=SMUT .